Dec 31, 2018

Xenon Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$6M
Previous year: $16K
+37400.0%
EPS
-$0.29
Previous year: -$0.45
-35.6%
Cash and Equivalents
$67.8M
Previous year: $20.5M
+230.7%
Free Cash Flow
-$7.41M
Previous year: -$6.9M
+7.4%
Total Assets
$122M
Previous year: $46.1M
+165.4%

Xenon Pharmaceuticals

Xenon Pharmaceuticals